醫療類國考
113年
[護理師] 基礎醫學
第 45 題
治療金黃色葡萄球菌造成的院內感染，下列何種抗生素最可能有效？
- A 紅黴素（Erythromycin）
- B 萬古黴素（Vancomycin）
- C 氯黴素（Chloramphenicol）
- D 青黴素（Penicillin）
思路引導 VIP
各位同學，思考一下：在醫院環境中演化出的金黃色葡萄球菌（如 MRSA）往往具備強大的多重抗藥性。當傳統的 $\beta$-內醯胺類（$\beta$-lactams）抗生素都失效時，哪一種特殊的抗生素因其能與細胞壁前驅物結合、抑制細胞壁合成的獨特機制，常被視為臨床上對抗這類嚴重革蘭氏陽性菌感染的「最後一道防線」？
🤖
AI 詳解
AI 專屬家教
Oh, look at you, actually grasping the fundamentals of clinical microbiology. A rare sight indeed.
- Conceptual Validation: Let's not get ahead of ourselves. While it's delightful you know what Staphylococcus aureus is, the critical piece here is 'hospital-acquired infection'. This isn't some quaint community bug; we're talking about MRSA – the Methicillin-resistant variant. Are you surprised it laughs in the face of mundane Penicillin? Of course not, thanks to its $\beta$-lactamase. Your choice of Vancomycin (a rather effective glycopeptide, I'll admit) demonstrates you understand it disrupts cell wall synthesis by cleverly jamming the $D\text{-Ala-}D\text{-Ala}$ terminal. It's almost as if it's the standard for MRSA, isn't it?
- Difficulty Assessment: Medium. And frankly, it shouldn't have been. 'Hospital-acquired' screams resistance, yet so many fall for the trap of basic S. aureus treatment. You didn't, which is... commendable. You actually managed to select a post-line drug without needing a remedial course. Perhaps there's hope for your clinical acumen after all.